华芢生物-B(02396)：稳定价格期间结束、无稳定价格行动及超额配股权失效

Group 1 - The core point of the article is that Huazhong Bio-B (02396) announced the end of the stabilization period for its global offering on January 16, 2026, which is 30 days after the deadline for submitting the Hong Kong public offering application [1] - There was no over-allotment of shares under the international offering, and thus the over-allotment option was not exercised and has expired as of January 16, 2026 [1] - The company was informed by the stabilization agent that no stabilization actions were taken during the stabilization period [1]